Medical Developments International has released a press release.
Cleansing Notice and Appendix 3B
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- Capital Raising - Placement and Share Purchase Plan
- FY18 Results Update
- USA Update
- Penthrox approved in Spain
- Penthrox approved in Italy and the Czech Republic
Later from Medical Developments International
- Penthrox Paediatric Trial Safety Update
- MVP signs exclusive Penthrox deal for China
- Penthrox is approved in Saudi Arabia
- Penthrox approved in Hong Kong
- Trading and market update
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International